ATE371455T1 - Verwendung von nicht feminisierenden östrogenen als retinoprotektive mittel zur behandlung von glaukom - Google Patents

Verwendung von nicht feminisierenden östrogenen als retinoprotektive mittel zur behandlung von glaukom

Info

Publication number
ATE371455T1
ATE371455T1 AT02761551T AT02761551T ATE371455T1 AT E371455 T1 ATE371455 T1 AT E371455T1 AT 02761551 T AT02761551 T AT 02761551T AT 02761551 T AT02761551 T AT 02761551T AT E371455 T1 ATE371455 T1 AT E371455T1
Authority
AT
Austria
Prior art keywords
glaucoma
treatment
retinoprotective
agents
feminizing estrogens
Prior art date
Application number
AT02761551T
Other languages
English (en)
Inventor
Iok-Hou Pang
Abbot Clark
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Application granted granted Critical
Publication of ATE371455T1 publication Critical patent/ATE371455T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/566—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol having an oxo group in position 17, e.g. estrone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT02761551T 2001-09-05 2002-09-03 Verwendung von nicht feminisierenden östrogenen als retinoprotektive mittel zur behandlung von glaukom ATE371455T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US31722501P 2001-09-05 2001-09-05

Publications (1)

Publication Number Publication Date
ATE371455T1 true ATE371455T1 (de) 2007-09-15

Family

ID=23232682

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02761551T ATE371455T1 (de) 2001-09-05 2002-09-03 Verwendung von nicht feminisierenden östrogenen als retinoprotektive mittel zur behandlung von glaukom

Country Status (16)

Country Link
EP (1) EP1423125B1 (de)
JP (1) JP2005501888A (de)
KR (1) KR100894385B1 (de)
CN (1) CN1551773A (de)
AR (1) AR038451A1 (de)
AT (1) ATE371455T1 (de)
AU (1) AU2002326807B2 (de)
BR (1) BR0212274A (de)
CA (1) CA2458468C (de)
DE (1) DE60222143T2 (de)
ES (1) ES2289134T3 (de)
MX (1) MXPA04002098A (de)
PL (1) PL206249B1 (de)
TW (1) TWI320712B (de)
WO (1) WO2003020284A1 (de)
ZA (1) ZA200401313B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040214806A1 (en) 2002-09-03 2004-10-28 Iok-Hou Pang Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma
WO2004091630A1 (ja) * 2003-04-18 2004-10-28 Advanced Medicine Research Institute 眼に適用する疾患治療剤
WO2004093882A1 (ja) * 2003-04-18 2004-11-04 Advanced Medicine Research Institute 眼に適用する疾患治療剤

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2123405C (en) * 1991-11-22 2008-01-15 Abbot F. Clark Angiostatic steroids
US6197833B1 (en) * 1995-07-24 2001-03-06 Apollo Biopharmaceutics, Inc. Neuroprotective effects of polycyclic phenolic compounds
US5521168A (en) * 1994-10-13 1996-05-28 Alcon Laboratories, Inc. Estrogen metabolites for lowering intraocular pressure
EP1343803A2 (de) * 2000-11-27 2003-09-17 EntreMed, Inc. 2-substituierte estrogene mit antiangiogenischer aktivität

Also Published As

Publication number Publication date
BR0212274A (pt) 2004-10-19
KR20040033012A (ko) 2004-04-17
WO2003020284A1 (en) 2003-03-13
JP2005501888A (ja) 2005-01-20
DE60222143T2 (de) 2008-06-05
EP1423125B1 (de) 2007-08-29
ES2289134T3 (es) 2008-02-01
EP1423125A4 (de) 2005-02-09
HK1064947A1 (en) 2005-02-08
AU2002326807B2 (en) 2007-08-23
MXPA04002098A (es) 2004-06-07
CA2458468C (en) 2010-08-24
AR038451A1 (es) 2005-01-19
PL374243A1 (en) 2005-10-03
DE60222143D1 (de) 2007-10-11
TWI320712B (en) 2010-02-21
PL206249B1 (pl) 2010-07-30
ZA200401313B (en) 2005-05-11
CA2458468A1 (en) 2003-03-13
EP1423125A1 (de) 2004-06-02
KR100894385B1 (ko) 2009-04-22
CN1551773A (zh) 2004-12-01

Similar Documents

Publication Publication Date Title
ATE308997T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
DE60023043D1 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE556059T1 (de) Pyrazolderivate zur behandlung von hiv
DE60234760D1 (de) Phenylindole zur behandlung von hiv
DE60204466D1 (de) Integrinhemmer zur behandlung von augenkrankheiten
DE60123238D1 (de) Zusammensetzungen zur behandlung von autoimmunkrankheiten
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE60218451D1 (de) 15-keto-prostaglandine zur behandlung arzneimittelinduzierter obstipation
EP1117431A4 (de) Behandlung von acidose
DE60238765D1 (de) Carbamatverbindungen zur behandlung von schmerz
ATE443060T1 (de) Benzoägüchinolinderivate zur behandlung von glaucom und kurzsichtigkeit
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis
DE60016047D1 (de) Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten
DE60103685D1 (de) Behandlung von Poriomania
DE60120990D1 (de) Verwendung von 3-bezoylphenylessigsäure-derivaten zur behandlung von netzhauterkrankungen
DE50212649D1 (de) Verwendung von desoxypeganin zur behandlung der klinischen depression
ATE371455T1 (de) Verwendung von nicht feminisierenden östrogenen als retinoprotektive mittel zur behandlung von glaukom
DE60120961D1 (de) Disulfid-derivate verwendbar zur behandlung von allergischen erkrankungen
DE60105053D1 (de) Zusammensetzungen zur behandlung von gewebe
ATE343387T1 (de) S-methyl-dihydro-ziprasidon zur behandlung von augenerkrankungen.
DE60103071D1 (de) Behandlung von flüssigkeiten
ATE226440T1 (de) Zusammensetzung zur behandlung von psoriasis

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties